HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Role of radiation in Hodgkin’s lymphoma treatment remains controversial
• AACI appoints new president
• AACR names journal editor
• ACS recognizes palliative ‘pathfinder’
• ASCO foundation presents awards
• ATA issues guidelines for anaplastic thyroid cancer management
• FU/mitomycin yielded positive long-term outcomes in anal carcinoma
• Multiple resections may extend life of patients with aggressive brain cancer
• Radiation plus PCV chemotherapy may become 
standard of care for anaplastic oligodendrogliomas
• Researcher receives achievement award
• Study: Medicare spending increased by 198.7% during past 3 decades
• Study sheds light on circulation patterns of sickle cells
• Study: Aspirin viable alternative to warfarin for healthy patients after TJA
• Thyroid association honors physician
• Vaccine shows promise in patients with metastatic melanoma
• Eliminating Medicare payments for consultations led to net increase in spending
• FDA accepts application for tivozanib in patients with renal cell carcinoma
• FDA approves Cometriq for patients with medullary thyroid cancer
• A 55-year-old male nonsmoker with metastatic lung carcinoma Munir Ghesani, MD, FACNM; Sam Altman, MD
• The ethics of treatment-related harm in stem cell transplantation William Wood, MD
• Addition of bortezomib to AML chemotherapy raised remission rates
• Adjuvant therapy may reduce risk of ocular surface squamous neoplasia recurrence
• Bone marrow biopsy offered minimal value to PET/CT staging of Hodgkin’s
• Breath analysis identified malignant pulmonary nodules
• Ciprofloxacin could prevent fever in some children with ALL Kamolwish Laoprasopwattana, MD
• Dermoscopy effectively diagnosed actinic keratosis in real time
• Early removal of low-grade gliomas appears more effective than watchful waiting
• Higher dietary glycemic intake increased risk for colon cancer recurrence
• High-volume hospitals show better mortality rates for ovarian cancer
• Low-dose aspirin reduced rate of major vascular events
• Mechlorethamine gel effectively treated patients with mycosis fungoides
• Novel biomarkers of aggressive, therapeutic targets identified for adult B-ALL
• Older breast cancer patients face HF, cardiomyopathy after trastuzumab
• Optimized fertility advice needed for Hodgkin's lymphoma survivors
• Robotic surgery shows promise for removal of voice box tumors
• Statin use reduced cancer-related mortality
• Three-drug intra-arterial chemotherapy for retinoblastoma may preserve globe
• Triple-negative breast cancer increased risk for local recurrence
• VTE common among patients with lung cancer receiving chemotherapy
• ARCTIC: Antiplatelet therapy not improved by monitoring platelet function
• Background liver proliferation linked to noncirrhotic HCC in patients with HCV
• Benefits of dabigatran against recurrent VTE maintained 1 year after drug discontinuation
• Bleeding rates after platelet transfusion with, without prophylaxis remain high
• Dabigatran performed better than warfarin following major bleeds
• Efficacy of letrozole varied by histology for patients with lobular carcinoma
• Extended relatives of colorectal cancer patients at elevated neoplasia risk
• Genotype may reduce toxicity in pediatric African-American and Asian patients with AML
• HDAC inhibitors may cause BRCA1-like environment in triple-negative cells
• Hepatocellular carcinoma survival rates increased during 30-year period
• Low hematocrit levels decreased risk of thrombosis among patients with polycythemia vera
• Many patients may have received inappropriate DAPT dose
• Meta-analysis suggests patients taking statins less likely to develop HCC
• Music reduced stress for patients undergoing Mohs surgery
• New agent, letrozole combination improved PFS in advanced breast cancer
• Prior surgery reduced success rate of sentinel lymph node biopsy
• Residual cells from triple-negative disease showed genetic diversity after chemotherapy
• Sentinel lymph node surgery may detect residual disease in node-positive breast cancer
• Transplant surgery lecture addresses over-prioritization of HCC patients
• Bosutinib: Another option for the treatment of CML Lisa K. Lohr, PharmD, BCPS, BCOP